Literature DB >> 7540065

Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells.

A Shibuya1, K Nagayoshi, K Nakamura, H Nakauchi.   

Abstract

We have established a cell culture system without stromal cells that allows the CD34+ hematopoietic progenitor cells (HPC) to differentiate into natural killer (NK) cells. CD34+Lin (CD3, CD16, CD56)- cells were purified using fluorescence-activated cell sorting from normal adult bone marrow (BM) and cultured for 28 days in medium supplemented with interleukin-2 (IL-2) and stem cell factor (SCF). NK (CD3-CD16-CD56+) cells were generated in a dose-dependent manner in response to SCF. NK cells originated from CD34+CD33+Lin- cells, but they were barely detectable in cultures of CD34+CD33-Lin- cells. However, on addition of IL-3, an induced differentiation of NK cells from CD34+CD33-Lin- cells was observed, although at a lower frequency. Supplementing of the cell cultures with SCF alone or both SCF and IL-3 for the first 7 days followed by IL-2 for the next 21 days is essential for production of NK cells from CD34+CD33+Lin- cells and from CD34+CD33-Lin- cells, respectively. These data provide direct evidence that NK cells arise from CD34+HPC and show the minimum lymphokine requirement for their differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540065

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy.

Authors:  T A Fehniger; E M Bluman; M M Porter; E Mrózek; M A Cooper; J B VanDeusen; S R Frankel; W Stock; M A Caligiuri
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 2.  Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.

Authors:  Martha Luevano; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

3.  Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells.

Authors:  Colin H Martin; Petter S Woll; Zhenya Ni; Juan Carlos Zúñiga-Pflücker; Dan S Kaufman
Journal:  Blood       Date:  2008-07-11       Impact factor: 22.113

4.  An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection.

Authors:  Chongfeng Xu; Junhong Ai; Qingxun Zhang; Ting Li; Xiaorong Wu; Zhengde Xie; Ziyuan Duan
Journal:  J Vis Exp       Date:  2018-03-30       Impact factor: 1.355

5.  The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells.

Authors:  Tiffany Hughes; Edward L Briercheck; Aharon G Freud; Rossana Trotta; Susan McClory; Steven D Scoville; Karen Keller; Youcai Deng; Jordan Cole; Nicholas Harrison; Charlene Mao; Jianying Zhang; Don M Benson; Jianhua Yu; Michael A Caligiuri
Journal:  Cell Rep       Date:  2014-06-19       Impact factor: 9.423

6.  The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0.

Authors:  Ritsuro Suzuki; Shigeki Ohtake; Jin Takeuchi; Masami Nagai; Yoshihisa Kodera; Motohiro Hamaguchi; Shuichi Miyawaki; Takahiro Karasuno; Shigetaka Shimodaira; Ryuzo Ohno; Shigeo Nakamura; Tomoki Naoe
Journal:  Int J Hematol       Date:  2010-01-29       Impact factor: 2.490

Review 7.  NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm.

Authors:  Ritsuro Suzuki
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

8.  Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.

Authors:  Bartosz Grzywacz; Nandini Kataria; Magdalena Sikora; Robert A Oostendorp; Elaine A Dzierzak; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

Review 9.  Biology and clinical impact of human natural killer cells.

Authors:  Sherif S Farag; Jeffrey B VanDeusen; Todd A Fehniger; Michael A Caligiuri
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

Review 10.  Development and functions of natural killer cells.

Authors:  Akira Shibuya
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.